Growth and activation of PI-3K/PKB and Akt by stromal cell-derived factor 1α in endometrial carcinoma cells with expression of suppressor endoprotein PTEN

Chinese Medical Journal

Volumn 119, Issue 5, 2006, Pages 378-383

  Li, Xiao Ping ^a   Zhao, Dan ^a   Gao, Min ^a   Zhao, Chao ^a   Wang, Jian Liu ^a   Wei, Li Hui ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Endometrial carcinoma; Stromal cell derived factor 1

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ENHANCED GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1ALPHA; ALPHA CHEMOKINE; PTEN PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL GROWTH; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL PROLIFERATION; DRUG EFFECT; ENDOMETRIUM TUMOR; FEMALE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINES, CXC; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 33645507599     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200603010-00005     Document Type: Article

References (23)

1. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997; 57:3935-3940.
2. Bussaglia E, del Rio E, Matias-Guiu X, Prat J. PTEN mutations in endometrial carcinomas: a molecular and clinicapathologic analysis of 38 cases. Hum Pathol 2000;31:312-317.
3. Zhang YJ, Wei LH, Li XP, Wang JL. Role of suppressor encoprotein PTEN in IGF-1 induced activation of ERK in endometrial carcinoma cells. Chin J Cancer (Chin) 2002; 21:724-730.
4. Feng Y, Broder CC, Kennedy PE, Berger EA. HIVA-1 entry cofactor: functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science 1996; 272:809-810.
5. Schrader A, Lechner 0, Templin M, Dittmar KE, Machtens S, Mengel M, et al. CXCR4/CXCL12 expression and signaling in kidney cancer. Br J Cancer 2002; 86:1250-1256.
6. Mizokami Y, Kajiyama H, Shibata K, Ino K, Kikkawa F, Mizutani S. Stromal cell-derived factor-1 alpha- induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma. Int J Cancer 2004;110: 652-659.
7. Yaginuma Y, Yamashita T, Ishiya T, Morizaki A, Katoh Y, Takahashi T, et al. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers. Mol Carcinog 2000; 27:110-116.
8. Kurarmoto H, Hamano M, Imai M. HEC-1 cells. Hum Cell 2002; 15:81-95.
9. Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of pre-B-cell stimulating factor. Proc Natl Acad Sci USA 1994; 91:2305-2309.
10. Balkwill F. Chemokine biology in cancer. Semin Immunol 2003; 15: 49-55.
11. Bradstock KF, Makrynikola V, Bianchi A, Shen W, Hewson J, Gottlieb DJ. Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia 2000; 14:882-888.
12. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill F. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 2001; 61:4961-4965.
13. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin in Cancer Biol 2004;14:171-179.
14. Eisenhardt A, Frey U, Tack M, Rosskopf D, Lummen G, Rubben H, et al. Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. Eur Urol 2005; 47:111-117.
15. Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, et al. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer 2005;114:182-189.
16. Ishikawa T, Nakashiro K, Hera S, Klosek SK, Li C, Shintani S, et al. CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma. Int J Oncol 2006; 28:61-66.
17. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 2002; 62:5930-5938.
18. Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA,et al. Expression of CXCR4 and CXCL12 SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003; 89:462-473.
19. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121:335-348.
20. Hall JM, Korach KS.Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 2003; 17:792-803.
21. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, et al. Stromal cell-derived factor 1 alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003;63:1969-1974.
22. Cantely LC, Neel BG. New insight into tumor suppression: PTEN suppresses tumorformation by restraining the phosphoinositide 3 kinase/AKTpathway. Proc Natl Acad Sci USA 1999; 96:4240-4245.
23. Waite KA, Eng C. Protean PTEN:Form and function. Am J Hum Genet 2002; 70:829-884.